[Clinical pharmacology of anticholinergic antiparkinson agents. A review with emphasis on acute toxicity].

Today, anticholinergic antiparkinsonian drugs are primarily used to ameliorate extrapyramidal side-effects induced by neuroleptic agents. Orphenadrine dominates quantitatively among these drugs in Norway, presumably because it is assumed to carry a lower risk of abuse. There are numerous reports of deaths following orphenadrine overdoses. Orphenadrine has complex pharmacokinetic properties and a narrow therapeutic index. After an overdose, it confers toxic effects of rapid onset to several organ systems. No specific and effective therapy for orphenadrine intoxication has been established. For the two other drugs in this class which are marketed in Norway, biperiden and benztropine, toxicity is mainly connected to their anticholinergic properties. Notably, no reports of lethalities after overdoses of biperiden seem to be available. A small number of accounts of deaths following benztropine intoxication have been published. Neither of these two agents, and benztropine in particular, has been subjected to comprehensive pharmacokinetic evaluations. The relatively extensive use of orphenadrine should be discouraged.
AuthorsP Gjerden, L Slørdal
JournalTidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række (Tidsskr Nor Laegeforen) Vol. 118 Issue 1 Pg. 53-5 (Jan 10 1998) ISSN: 0029-2001 [Print] NORWAY
Vernacular TitleAntikolinerge antiparkinsonmedikamenters kliniske farmakologi. En oversikt med vekt på akutt toksisitet.
PMID9481912 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Antiparkinson Agents
  • Muscle Relaxants, Central
  • Biperiden
  • Benztropine
  • Orphenadrine
  • Antiparkinson Agents (poisoning)
  • Benztropine (poisoning)
  • Biperiden (poisoning)
  • Drug Overdose
  • Humans
  • Muscle Relaxants, Central (poisoning)
  • Orphenadrine (poisoning)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: